Benchmarking Integrated Care for People Living With Huntington's Disease in England
NCT ID: NCT05828992
Last Updated: 2023-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2023-02-28
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this anonymous survey is to benchmark integrated care from the perspective of service users in adults living with Huntington's Disease, including informal caregivers. The main question it aims to answer is: Is standard of care for people living with HD in England person-centred integrated care from the perspective of service users?
Participants will complete a one-time anonymous survey either online or on paper, according to their preference, that takes an average of 20-30 minutes. Participants can take breaks as needed, picking up the survey from where it was paused.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Caregiver Burden in Huntington's Disease
NCT02876445
Skills of Home Helpers for a Better Quality of Life for Adults With Huntington's Disease Living at Home
NCT04411238
Families Affected by Dementia: A Survey of Caregivers
NCT02095327
Empowerment Intervention for Persons With Young Onset Dementia
NCT02937883
Impact of Apathy on Caregiving in HD. Version 1
NCT05913154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two surveys were identified covering people's needs in the UK, dated from 2006 and 2010. When looking for models or approaches tested to improve outcomes for people living with HD, no studies were found. This is an underserved population with complex needs and care gaps that remain unaddressed.
Little is known about to what extent people living with HD are experiencing care coordination between services and sectors in England. Integrate-HD aims to find out what good, joined-up care looks like. The study will explore the views and experiences of people living with HD, to identify the changes needed to improve people's care and quality of life.
Integrate-HD is a national survey to benchmark integrated care from the perspective of people living with HD, including informal caregivers.
The study objectives are to:
1. Characterise and classify systems/organisations in England involved in HD care in relation to person-centred integrated care from the perspective of users.
2. Identify areas considered integrated by service users.
3. Identify areas considered fragmented by service users.
4. Map care resources used by people living with HD in England.
5. Identify unmet care needs that need improvement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Person at risk
Survey personalised for people living at risk of developing Huntington's Disease, meaning they have a parent diagnosed with HD but the person themselves have not undertaken a genetic test.
No intervention administered
Survey only to gather people's experiences, opinions and needs.
Person HD gene positive asymptomatic
Survey personalised for people that tested positive in their predictive genetic test but have not been yet diagnosed with clinical HD (manifest HD).
No intervention administered
Survey only to gather people's experiences, opinions and needs.
Person HD gene positive symptomatic
Survey personalised for people that tested positive in their predictive genetic test and have been diagnosed with clinical HD (manifest HD).
No intervention administered
Survey only to gather people's experiences, opinions and needs.
Informal caregiver
Survey personalised for people caring for another person diagnosed with HD.
No intervention administered
Survey only to gather people's experiences, opinions and needs.
Former informal caregiver
Survey personalised for people that have cared for another person diagnosed with HD in the last 3 years.
No intervention administered
Survey only to gather people's experiences, opinions and needs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention administered
Survey only to gather people's experiences, opinions and needs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A person at risk of HD (where at least one parent is diagnosed with HD, therefore their offspring has 50% chance of developing the disease);
* A person diagnosed with HD symptomatic or asymptomatic (after undergoing gene testing and having a positive result);
* An informal caregiver supporting someone living with HD;
* A former informal caregiver with experience of supporting someone living with HD in the last 3 years.
Exclusion Criteria
* Not fluent in English;
* A person without capacity.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute for Health Research, United Kingdom
OTHER_GOV
Central Coast Research Institute for Integrated Care, Australia
UNKNOWN
University Hospital Southampton NHS Foundation Trust
OTHER
University of Southampton
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandra B Pires, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Southampton
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Southampton
Southampton, Hampshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERGO number: 77725
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.